Oak Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Oak Asset Management, LLC

$291 Million
Q3 2025

A detailed history of Oak Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Oak Asset Management, LLC holds 1,100 shares of REGN stock, worth $762,850. This represents 0.21% of its overall portfolio holdings.

Number of Shares

1,100

Previous 1,510 27.15%

Holding current value

$762,850

Previous $792,000 21.97%

% of portfolio

0.21%

Previous 0.28%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$534.91 - $598.71 $219,313 - $245,471	-410 Reduced 27.15%	1,100 $618,000
Q2 2025 Jul 11, 2025	SELL	$483.07 - $625.6 $60,383 - $78,200	-125 Reduced 7.65%	1,510 $792,000
Q3 2024 Oct 07, 2024	SELL	$1024.09 - $1201.76 $153,613 - $180,264	-150 Reduced 8.4%	1,635 $1.72 Million
Q2 2024 Jul 12, 2024	SELL	$883.2 - $1071.19 $22,080 - $26,779	-25 Reduced 1.38%	1,785 $1.88 Million
Q1 2024 Apr 17, 2024	SELL	$902.69 - $993.35 $45,134 - $49,667	-50 Reduced 2.69%	1,810 $1.74 Million

Q4 2023 Jan 23, 2024	SELL	$775.18 - $881.7 $19,379 - $22,042	-25 Reduced 1.33%	1,860 $1.63 Million
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $289,414 - $314,219	-410 Reduced 17.86%	1,885 $1.36 Million
Q3 2022 Oct 18, 2022	BUY	$573.97 - $724.32 $1.32 Million - $1.66 Million	2,295 New	2,295 $1.58 Million
Q2 2022 Jul 15, 2022	SELL	$548.35 - $738.84 $1.26 Million - $1.7 Million	-2,295 Closed	0 $0
Q2 2021 Jul 14, 2021	BUY	$472.8 - $558.54 $1.09 Million - $1.28 Million	2,295 New	2,295 $1.28 Million
Q1 2021 Apr 27, 2021	SELL	$446.73 - $548.2 $1.03 Million - $1.26 Million	-2,295 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$299.6 - $414.82 $687,582 - $952,011	2,295 New	2,295 $681,000
Q1 2018 Apr 23, 2018	SELL	$315.82 - $393.78 $235,285 - $293,366	-745 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $267,179 - $350,112	745	745 $280,000

Others Institutions Holding REGN

# of Institutions

1,469

Shares Held

86.5M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Asset Management, LLC with notifications on news.

Account

Oak Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History